Answers are grounded in this paper and cite their sources.
We divided a group of Attention Deficit Hyperactivity Disorder (ADHD) boys into two groups determined by the results of EEG and visual ERP tests--those who had excessive EEG background slowing, EEG epileptiform activity or abnormally high amplitude ERP waves (the "E-ADD" group), and those with normal EEG and ERP (the "ADD" group). The subjects of each group were then given either a dose of methylphenidate (Ritalin, MPH), sodium valproate (Depakene, VPA) or placebo, and repeated visual ERPs one hour later. Following both medications there was a significant suppression of the amplitude of the N3, the "slow negative" wave of the ERP, in the E-ADD group but not in the ADD group. The effect of VPA and MPH in ADHD children may be related to the electrophysiological (EEG, ERP) background. Both medications may have a similar effect on arousal processes in ADHD.
No takes yet. Share an insight, caveat, or question.
Yitzchak Frank (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: